Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1-positive locally advanced/metastatic NSCLC

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33817

Title:	Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1-positive locally advanced/metastatic NSCLC
Authors:	MOK, T. S. K.; WU, Y-L.; KUDABA, I.; KOWALSKI, D. M.; CHO, B. C.; TURNA, H. Z.; CASTRO JR., G. de; SRIMUNINNIMIT, V.; LAKTIONOV, K. K.; BONDARENKO, I.; KUBOTA, K.; CAGLEVIC, C.; KARASZEWSKA, B.; DANG, T.; YIN, L.; PENROD, J.; LOPES, G.
Citation:	ANNALS OF ONCOLOGY, v.30, suppl.2, p.38-38, 2019
Appears in Collections:	Comunicações em Eventos - FM/MDR Departamento de Radiologia - FM/MDR Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - LIM/24 LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:

There are no files associated with this item.